Company Logo
Editing New Medical Product Launch Template Structure.
July 23, 2026
New Medical Product Launch Framework

Launch Plan Sign-Off Record — Version 3

Reviewer Status Date
Darin Dixon - VP Pending —
Alicia Anselmo - Service Coordination Manager Pending —
Carlos Rangel - Service Manager Pending —
David Vincent III - Service Manager Pending —
Jean Aragundi - Service Manager Pending —
Mikulich Ryan - VP Sales Pending —
Gene Borbone - Service Operations Director ✓ Approved Jul 29, 2026
BPD - Brief Product Description: A concise overview of the new medical product and its key features.
VP - Value Proposition: A clear statement of the benefits the product offers to patients, HCPs, and the healthcare system.
Target Audience: Primary user groups, key clinical specialties, and purchasing stakeholders.
Key Launch Objectives: Measurable goals including market share adoption rate, revenue targets, and time-to-market.
Overall Launch Strategy: High-level summary of the phased commercialization approach.
In Review Awaiting approval — 1 of 7 reviewers have signed off. Version 3

📋 Launch Plan Sign-offs

Darin Dixon - VP
Pending
Alicia Anselmo - Service Coordination Manager
Pending
Carlos Rangel - Service Manager
Pending
David Vincent III - Service Manager
Pending
Jean Aragundi - Service Manager
Pending
Mikulich Ryan - VP Sales
Pending
Gene Borbone - Service Operations Director
Approved by Gene Borbone on Jul 29, 2026 5:35pm
Approved

👥 Manage Launch Reviewers

Darin Dixon - VP (ID: 68) Alicia Anselmo - Service Coordination Manager (ID: 54) Carlos Rangel - Service Manager (ID: 25) David Vincent III - Service Manager (ID: 231) Jean Aragundi - Service Manager (ID: 1) Mikulich Ryan - VP Sales (ID: 1029) Gene Borbone - Service Operations Director (ID: 93)

🕘 Launch Version History — Editing Version 3

Version 2 — New Medical Product Launch Framework
Jul 24, 2026 10:35am by Jean
Version 1 — APH550
Jul 23, 2026 2:52pm by Jean
Version 1 — New Medical Product Launch Framework
Jul 23, 2026 2:56pm by Jean

1.0 EXECUTIVE SUMMARY

No criteria logged for this section.
💡 Tip: Use 'Label -- Value' format for top metadata grid items (e.g. Target Launch Date -- Q3 2026). Use 'Heading | Content' for subtitles[cite: 1].
Inject Role Tag at Cursor:

2.0 PRODUCT OVERVIEW

    Detailed Product Description
  1. Comprehensive technical specs, features, and mechanism of action.
    2. Indications & Contraindications
  2. Clearly defined clinical uses, scope of treatment, and restrictions.
    3. Clinical Evidence
  3. Summary of supporting clinical trial data, peer-reviewed publications, and efficacy findings.
    4. Regulatory Status
  4. FDA clearances (510k/PMA), CE Mark status, and post-market compliance requirements.
    5. Competitive Landscape
  5. Analysis of direct and indirect competitor solutions, strengths, and differentiators.
    6. Intellectual Property
  6. Overview of issued patents, trademarks, and pending protection filings.
Inject Role Tag at Cursor:

3.0 TARGET AUDIENCE AND MARKET ANALYSIS

    Target Patient Population
  1. Demographics, disease prevalence, and unmet therapeutic needs.
    2. Target Healthcare Professionals (HCPs)
  2. Key specialties, prescribers, operators, and clinical personnel.
    3. Market Size & Opportunity
  3. Total Addressable Market (TAM), growth projections, and market drivers.
    4. Market Segmentation
  4. Key subgroups requiring tailored positioning or specialty outreach.
    5. Key Opinion Leaders (KOLs)
  5. Prominent industry experts identified for advocacy and scientific advisory.
    6. Payers & Reimbursement Landscape
  6. Coverage policies, coding/billing considerations, and access barriers.
Inject Role Tag at Cursor:

4.0 LAUNCH STRATEGY AND PLAN

    Overall Positioning & Messaging
  1. Core marketing messaging tailored across distinct target personas.
    2. Go-to-Market Strategy
  2. Direct sales force execution combined with authorized distribution partners.
    3. Phased Launch Approach
  3. Rollout stages across priority geographic regions and clinical tier accounts.
    4. Sales & Distribution Strategy
  4. Sales team structures, quota targets, training certification, and logistics.
    5. Marketing & Communications
  5. Pre-launch awareness, launch events, PR outreach, and conference presence.
    6. Medical Affairs Strategy
  6. Scientific engagement plans, investigator-initiated studies, and publication plans.
    7. Market Access & HEOR
  7. Health economics research, value dossiers for payers, and formulary approvals.
    8. Digital Strategy
  8. Digital campaign presence, web portals, social engagement, and EHR integration options.
    9. Customer Support & Training
  9. Comprehensive hands-on training programs, support routing, and complaint workflows.
Inject Role Tag at Cursor:

5.0 LAUNCH TIMELINE AND MILESTONES

    Pre-Launch Phase
  1. Milestone tracking for regulatory approvals, inventory staging, and sales enablement.
    2. Launch Phase
  2. Execution timeline for initial commercial availability and announcement activities.
    3. Post-Launch Phase
  3. Post-rollout growth monitoring, adoption reviews, and lifecycle expansion planning.
    4. Project Management Integration
  4. Gantt chart mapping and cross-departmental deadline alignment.
Inject Role Tag at Cursor:

6.0 BUDGET AND RESOURCES

    Detailed Budget Allocation
  1. Expense breakdown across marketing, clinical, sales, regulatory, and logistics.
    2. Resource Allocation
  2. Personnel staffing, equipment inventory, and operational tools required.
    3. Key Performance Indicators (KPIs)
  3. Tracking target adoption, lead conversion, revenue, and unit placement.
    4. ROI Projections
  4. Financial forecasts, gross margin metrics, and break-even timelines.
Inject Role Tag at Cursor:

7.0 RISK ASSESSMENT AND MITIGATION

    Identification of Potential Risks
  1. Analysis of regulatory delays, supply chain disruptions, or competitive counter-strategies.
    2. Mitigation Strategies
  2. Action plans and contingency procedures for identified high-impact risks.
    3. Monitoring & Trigger Protocols
  3. Ongoing risk review cadence and execution triggers for contingency plans.
Inject Role Tag at Cursor:

8.0 TEAM AND RESPONSIBILITIES

    Launch Team Structure
  1. Cross-functional steering committee definition.
    2. Roles & Responsibilities
  2. Specific deliverables assigned across product, clinical, service, and marketing teams.
    3. Communication Plan
  3. Meeting cadence, status dashboards, and escalation channels.
Inject Role Tag at Cursor:

9.0 POST-LAUNCH EVALUATION

    KPI Tracking & Metrics Cadence
  1. Data collection protocols for ongoing performance reporting.
    2. Regular Review Meetings
  2. Schedule for monthly/quarterly progress reviews and tactical pivots.
    3. Feedback Collection
  3. Systematic survey collection from clinicians, field service, and sales reps.
    4. Lifecycle Management
  4. Ongoing product enhancements, software updates, and line extension roadmaps.
Inject Role Tag at Cursor:

10.0 APPENDICES

  1. Market Research Studies & Clinical Summaries
  2. Regulatory Approval Files & Clearance Documentation
  3. Reimbursement Dossiers & Coding Guidance Sheets
  4. Sales & Service Technical Training Decks
Inject Role Tag at Cursor: